Invention Grant
- Patent Title: Pharmaceutical composition
-
Application No.: US14718595Application Date: 2015-05-21
-
Publication No.: US09622975B2Publication Date: 2017-04-18
- Inventor: Moise Azria , Simon David Bateman , Anasuya Ashok Ghosh , Shoufeng Li , Alan Edward Royce
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Pokalsky Wilczynski Brozek, LLP
- Main IPC: A61K38/29
- IPC: A61K38/29 ; A61K9/20 ; A61K31/198 ; A61K38/23

Abstract:
The present invention provides oral pharmaceutical compositions that enable the successful delivery of drugs in a pharmaceutically effective amount, particularly poly (amino acids) such as peptides, peptidomimetics and proteins. e.g. hormones to a subject via oral administration to accomplish the desired therapeutic effect. The oral pharmaceutical composition comprising a poly (amino acid) as the active ingredient, e.g. a peptide or protein, shows a rapid disintegration and/or dissolution such that the active ingredient is able to attain a therapeutic effect.
Public/Granted literature
- US20150250729A1 PHARMACEUTICAL COMPOSITION Public/Granted day:2015-09-10
Information query
IPC分类: